In the published article, there was an error in Figure 1 as published. The dose of IVIG was listed as 2 mg/kg over 2–5 days, when it should be 2 g/kg over 2–5 days.
Figure 1.
Flow diagram for evaluation and management of NORSE/FIRES. NORSE, New Onset Refractory Status Epilepticus; FIRES, Febrile infection-related epilepsy syndrome; SE, Status epilepticus; RSE, Refractory status epilepticus; GAD, Gadolinium; MRV, Magnetic resonance venogram; MRA, Magnetic resonance angiography; CEEG, Continuous EEG; USG, Ultrasonography; PET, Positron emission tomography; HSV, Herpes simplex virus; VNS, Vagus nerve stimulator. 
Diagnostic consideration. 
Diagnostic procedure. 
Treatment. 
Outcome assessment. 
Management timeline.
The corrected Figure 1 and its caption appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.